May 22, 2017 7:30 am EDT EyeGate Receives Milestone Payment from Valeant Pharmaceuticals for EGP-437 for post-operative ocular inflammation and pain in ocular surgery patients
May 8, 2017 8:30 am EDT EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
May 4, 2017 7:30 am EDT EyeGate Submits Investigational Device Exemption (IDE) Filing for Second Pilot Study of Ocular Bandage Gel
Mar 13, 2017 7:30 am EDT EyeGate Pharma Strengthens Scientific Advisory Board with Appointments of Daniel S. Durrie, M.D. and Randall J. Olson, M.D.
Feb 23, 2017 4:08 pm EST EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update
Jan 30, 2017 8:30 am EST EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of Ocular Bandage Gel in Corneal Epithelial Defects
Jan 24, 2017 8:30 am EST EyeGate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 13th Annual Investor Conference